A detailed history of Simplex Trading, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,690 shares of TERN stock, worth $21,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,690
Previous 21,243 82.63%
Holding current value
$21,623
Previous $144,000 79.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$6.49 - $10.8 $113,918 - $189,572
-17,553 Reduced 82.63%
3,690 $30,000
Q2 2024

Jul 25, 2024

BUY
$4.54 - $8.2 $96,443 - $174,192
21,243 New
21,243 $144,000
Q4 2023

Feb 02, 2024

BUY
$3.37 - $6.86 $572 - $1,166
170 New
170 $1,000
Q2 2023

Aug 04, 2023

BUY
$7.35 - $13.29 $300,504 - $543,361
40,885 New
40,885 $357,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.